by Editor | Sep 21, 2023 | Abortion, Fetal & Vaccine Research, Vaccines
Two RSV (Respiratory Syncytial Virus) vaccines have been approved in 2023 – Arexvy (GSK) and Abrysvo (Pfizer). Arexvy is recommended for adults over 60 years of age and Abrysvo has also been recommended for administration to expectant mothers between 32 and 36...
by Editor | Feb 28, 2023 | Exemptions, Legislative, News, Vaccines
The table was set for this when the Advisory Committee on Immunization Practices (ACIP) recommended the addition of COVID-19 vaccination to the child and adult immunization schedule, back in October of 2022. The vote was unanimous in support of the recommendation. The...
by Editor | Jan 29, 2023 | Abortion, Fetal & Vaccine Research, Legislative, News
The following item is the topic of our current weekly newsletter. This is a very encouraging development, as passage in Texas will have nationwide effects. Please take the time to make you support heard, whether you live in Texas or not. Call, email or send personal...
by Editor | Oct 21, 2022 | Abortion, Exemptions, News, Vaccines
The CDC’s Advisory Committee voted yesterday, October 20th, 2022, endorsing the addition of Covid-19 vaccines to the CDC’s Vaccination Schedule. The endorsement affects childhood and adult vaccination schedules, and the vote was unanimous in support of...
by Editor | Aug 4, 2022 | Abortion, Fetal & Vaccine Research, News
And there are monsters we imagine. Those we conjure up often drive us to distraction, and that is neither good nor productive. The Senomyx issue has become more and more visible in recent months, and it has overflowed the banks. I feel compelled to comment...
